SEMAGLUTIDE 10MG

Semaglutide is a synthetic peptide research compound studied in laboratory settings as a long-acting analog of glucagon-like peptide-1 (GLP-1). As a GLP-1 receptor agonist, semaglutide is examined for its interaction with metabolic and incretin signaling research models. Each vial from Central Peptides contains 10 mg of high-purity semaglutide, third-party verified and supplied with a batch-specific Certificate of Analysis (COA) for research use only. As one of the most studied GLP-1 analogs in metabolic research, semaglutide remains a frequently requested compound among Canadian laboratories.

Semaglutide Research Applications

Semaglutide is a 31-amino-acid synthetic peptide analog based on the native human GLP-1(7-37) sequence, sharing 94% sequence homology with human GLP-1. It was engineered with two key structural modifications: an Aib (alpha-aminoisobutyric acid) substitution at position 8 that provides resistance to DPP-4 enzymatic degradation, and a C18 fatty diacid chain conjugated via a hydrophilic linker that enables albumin binding and an extended half-life.

In controlled laboratory environments, researchers study semaglutide for its high-affinity binding to the GLP-1 receptor (GLP-1R) and its role in incretin pathway research. Research focuses on receptor activation, glucose-dependent signaling models, and comparative studies with other GLP-1 and incretin analogs such as tirzepatide and retatrutide.

Common research areas where semaglutide is examined include:

• GLP-1 receptor (GLP-1R) binding and activation research
• Incretin signaling and glucose-dependent pathway models
• Metabolic and body-composition research models
• Comparative studies with other GLP-1 and incretin analogs

Purity and Quality Verification

Every batch of semaglutide sold by Central Peptides is manufactured under controlled synthesis and purification processes to ensure stability, consistency, and structural integrity for scientific research applications. Our compounds are independently tested and verified at 99% purity through High-Performance Liquid Chromatography (HPLC) and mass spectrometry.

Each order includes access to a batch-specific Certificate of Analysis, allowing researchers to verify identity, purity percentage, and testing details before use. Because semaglutide is a complex modified peptide, verifying compound identity and purity through a COA is especially important. This batch-level traceability is part of our commitment to transparency and quality control across our full research catalog.

Product Specifications

• Compound: Semaglutide (GLP-1 analog)
• Structure: 31-amino-acid peptide, Aib8 substitution, C18 diacid modification
• Quantity: 10 mg per vial
• Purity: 99% (HPLC verified)
• Physical form: Lyophilized powder
• Lab testing: In-house HPLC and mass spectrometry
• COA: Batch-specific, available for every order
• View COA here: Lab Results | CentralPeptides.ca

Storage and Handling

Semaglutide is supplied as a lyophilized (freeze-dried) powder for maximum stability during shipping and storage. Lyophilization removes moisture from the compound, which helps preserve its structural integrity over time and allows it to remain stable during transit. For long-term integrity, store the lyophilized compound sealed in a cool, dry environment away from light.

Once reconstituted for research, semaglutide is soluble in bacteriostatic water and should be kept refrigerated at 2-8°C. To preserve compound integrity, aliquot the reconstituted material to avoid repeated freeze-thaw cycles, and use within an appropriate window to maintain consistency in research results.

Shipping Across Canada

Central Peptides ships semaglutide and all research compounds across Canada in discreet, temperature-conscious packaging. Orders are typically processed within 24 hours and delivered within 3 to 5 business days. Free delivery is available on qualifying orders over the threshold listed at checkout.

As a Canadian-based supplier, we offer domestic fulfillment, which means faster delivery times and fewer customs complications compared to ordering from international sources. Every shipment is packaged to protect the compound during transit and to maintain privacy.

Important Notice

• This product is intended for laboratory research and scientific purposes only.
• It is not approved by Health Canada, the FDA, or any other regulatory authority for human or veterinary use in this research-grade form.
• This product is not intended to diagnose, treat, cure, or prevent any disease.
• By purchasing this product, customers acknowledge that it is strictly for research use only.

Buyers are responsible for conducting their own research and understanding the characteristics and intended use of this product prior to purchase.

For additional reference data on this compound, see PubChem: PubChem